{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:56:53Z","timestamp":1790006213837,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.intimp.2007.11.006","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T20:34:28Z","timestamp":1204576468000},"page":"442-452","source":"Crossref","is-referenced-by-count":17,"title":["Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects"],"prefix":"10.1016","volume":"8","author":[{"given":"Anette","family":"Sundstedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Celander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Hedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2007.11.006_bib1","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.91.19.8945","article-title":"Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy","volume":"91","author":"Dohlsten","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2007.11.006_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.2910620418","article-title":"Tumor-reactive superantigens suppress tumor growth in humanized SCID mice","volume":"62","author":"Lando","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2007.11.006_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1054\/bjoc.2001.1891","article-title":"Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen","volume":"85","author":"Forsberg","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2007.11.006_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjc.6603567","article-title":"A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma","volume":"96","author":"Shaw","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2007.11.006_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.2524876","article-title":"V beta-specific stimulation of human T cells by staphylococcal toxins","volume":"244","author":"Kappler","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.intimp.2007.11.006_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(89)90980-X","article-title":"The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice","volume":"56","author":"White","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2007.11.006_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-065X.1989.tb00003.x","article-title":"T-cell responses to Mls and to bacterial proteins that mimic its behavior","volume":"107","author":"Janeway","year":"1989","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2007.11.006_bib8","first-page":"96","article-title":"Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins","volume":"71","author":"Dohlsten","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2007.11.006_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ijc.2910540321","article-title":"Superantigen-induced cytokines suppress growth of human colon-carcinoma cells","volume":"54","author":"Dohlsten","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2007.11.006_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0008-8749(90)90218-G","article-title":"Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells","volume":"129","author":"Hedlund","year":"1990","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1097-0215(19960927)68:1<109::AID-IJC19>3.0.CO;2-6","article-title":"Immune response during tumor therapy with antibody-superantigen fusion proteins","volume":"68","author":"Rosendahl","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2007.11.006_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bjc.6690701","article-title":"The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens","volume":"81","author":"Litton","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2007.11.006_bib13","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.4049\/jimmunol.160.11.5309","article-title":"Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens","volume":"160","author":"Rosendahl","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib14","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1073\/pnas.92.21.9791","article-title":"Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo","volume":"92","author":"Dohlsten","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2007.11.006_bib15","first-page":"1607","article-title":"Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses","volume":"150","author":"Litton","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.intimp.2007.11.006_bib16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","article-title":"Cytokine therapeutics: lessons from interferon alpha","volume":"91","author":"Gutterman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2007.11.006_bib17","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2007.11.006_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0167-5699(96)10027-X","article-title":"The neglected role of type I interferon in the T-cell response: implications for its clinical use","volume":"17","author":"Belardelli","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.intimp.2007.11.006_bib19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2007.11.006_bib20","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.161.4.1947","article-title":"Type I IFNs enhance the terminal differentiation of dendritic cells","volume":"161","author":"Luft","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib21","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.intimp.2007.11.006_bib22","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.intimp.2007.11.006_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0008-8749(90)90302-8","article-title":"Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha\/beta","volume":"126","author":"von Hoegen","year":"1990","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib24","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.153.10.4604","article-title":"IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS\/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS\/A cells","volume":"153","author":"Ferrantini","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib25","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1073\/pnas.88.20.9287","article-title":"Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents","volume":"88","author":"Dohlsten","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2007.11.006_bib26","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/j.1460-2075.1995.tb07300.x","article-title":"Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A","volume":"14","author":"Abrahmsen","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.intimp.2007.11.006_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jss.2003.09.005","article-title":"The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line","volume":"116","author":"Badgwell","year":"2004","journal-title":"J Surg Res"},{"key":"10.1016\/j.intimp.2007.11.006_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.164.2.567","article-title":"IFN-{alpha}-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs","volume":"164","author":"Hiroishi","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib29","first-page":"117","article-title":"Superantigens anergize cytokine production but not cytotoxicity in vivo","volume":"82","author":"Sundstedt","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2007.11.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.1830260102","article-title":"Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma","volume":"26","author":"Litton","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2567.1998.00562.x","article-title":"T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A","volume":"95","author":"Sundstedt","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2007.11.006_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(02)00650-2","article-title":"The biological treatment of renal-cell carcinoma and melanoma","volume":"3","author":"Nathan","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.intimp.2007.11.006_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.2910600216","article-title":"IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA\/2 mice and decreases their tumorigenicity in syngeneic C57BL\/6 mice","volume":"60","author":"Kaido","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2007.11.006_bib34","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1200\/JCO.2000.18.9.1928","article-title":"Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma","volume":"18","author":"Motzer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2007.11.006_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1359-6101(01)00022-3","article-title":"Interferon-alpha in tumor immunity and immunotherapy","volume":"13","author":"Belardelli","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.intimp.2007.11.006_bib36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity","volume":"265","author":"Kagi","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.intimp.2007.11.006_bib37","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1016\/S0021-9258(17)39328-6","article-title":"Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes","volume":"260","author":"Masson","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2007.11.006_bib38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(94)90376-X","article-title":"Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells","volume":"76","author":"Heusel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2007.11.006_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01754407","article-title":"Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells","volume":"36","author":"Hedlund","year":"1993","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.intimp.2007.11.006_bib40","first-page":"1165","article-title":"Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA\/ionomycin","volume":"12","author":"Mori","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.intimp.2007.11.006_bib41","first-page":"177","article-title":"Pretreatment expression of the perforin gene by circulating CD8(+) T lymphocytes predicts biochemical response to interferon-alpha in patients with chronic hepatitis C","volume":"11","author":"Balian","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.intimp.2007.11.006_bib42","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/eji.1830210827","article-title":"Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo","volume":"21","author":"MacDonald","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/1074-7613(94)90084-1","article-title":"Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo","volume":"1","author":"Kearney","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2007.11.006_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2007.11.006_bib45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/eji.1830260204","article-title":"Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression","volume":"26","author":"Akbar","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2007.11.006_bib46","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1073\/pnas.95.7.3810","article-title":"Cytokine-induced survival of activated T cells in vitro and in vivo","volume":"95","author":"Vella","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2007.11.006_bib47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","article-title":"Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo","volume":"14","author":"Le Bon","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2007.11.006_bib48","first-page":"5795","article-title":"The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice","volume":"58","author":"Belardelli","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2007.11.006_bib49","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1158\/0008-5472.CAN-04-1975","article-title":"Administration of IFN-{alpha} enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine","volume":"65","author":"Prell","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2007.11.006_bib50","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1158\/0008-5472.CAN-05-3396","article-title":"Immunization of stage IV melanoma patients with Melan-A\/MART-1 and gp100 peptides plus IFN-{alpha} results in the activation of specific CD8+ T cells and monocyte\/dendritic cell precursors","volume":"66","author":"Di Pucchio","year":"2006","journal-title":"Cancer Res"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757690700361X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757690700361X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T20:23:11Z","timestamp":1684268591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757690700361X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S156757690700361X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2007.11.006","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}